Kolexia
Jacqueroux Elodie Pharmacien
Jacqueroux Elodie
Pharmacien
Hôpital Nord CHU Saint-Étienne - Loire
Saint-Priest-en-Jarez, France
22 Activités
111 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Athérosclérose Calcification vasculaire Glycoprotéines Glycoprotéine P Protéine S Transporteurs ABC Membre-2 de la sous-famille G des transporteurs à cassette liant l'ATP Anticoagulants

Collaborateurs

Voir plus
Delavenne Xavier
Delavenne Xavier
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Mismetti Patrick
Mismetti Patrick
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Bertoletti Laurent
Bertoletti Laurent
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Clotagatide Anthony
Clotagatide Anthony
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
Sanofi
1 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Using 99mTc-(V)-DMSA to follow the vascular calcification process in vascular smooth muscle cells based on pit-1 expression.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...   15 juin 2020
Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V   13 janvier 2020
In vitro assessment of P-gp and BCRP transporter-mediated drug-drug interactions of riociguat with direct oral anticoagulants.
Fundamental & clinical pharmacology   28 août 2019
The parallel reaction monitoring-based high resolution mass spectrometry: a new validated method for the quantification of proteins
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, 12–14 June 2019, Lyon, France   05 juin 2019
Pharmacological characterization of the 3D MucilAir™ nasal model.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V   03 avril 2019
In Vitro Comparison of the Role of P-Glycoprotein and Breast Cancer Resistance Protein on Direct Oral Anticoagulants Disposition.
European journal of drug metabolism and pharmacokinetics   04 septembre 2018
Comparison of validated Caco-2 and MDCKs in vitro cell models for drug transport studies
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, 12–14 June 2018, Toulouse, France   31 mai 2018
In Vitro Assessment of Pharmacokinetic Drug-Drug Interactions of Direct Oral Anticoagulants: Type 5-Phosphodiesterase Inhibitors Are Inhibitors of Rivaroxaban and Apixaban Efflux by P-Glycoprotein.
The Journal of pharmacology and experimental therapeutics   23 mars 2018
Prescription et administration en pédiatrie : les difficultés à atteindre la prise en charge médicamenteuse idéale
Le Pharmacien Hospitalier et Clinicien   01 septembre 2015
Analysis of the question-answer activity of a hospital pharmacy. Example of the handling of drug interactions.
Annales pharmaceutiques francaises   12 novembre 2014